Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 8—August 2005
Research

Influenza A (H3N2) Outbreak, Nepal

Luke T. Daum*†Comments to Author , Michael Shaw‡, Alexander I. Klimov‡, Linda C. Canas*, Elizabeth A. Macias*, Debra Niemeyer*, James K. Chambers†, Robert Renthal†, Sanjaya K. Shrestha§, Ramesh P. Acharya¶, Shankar P. Huzdar¶, Nirmal Rimal¶, Khin S. Myint#, and Philip Gould*
Author affiliations: *Air Force Institute for Operational Health, Brooks City Base, San Antonio, Texas; †University of Texas, San Antonio, Texas; ‡Centers for Disease Control and Prevention, Atlanta, Georgia; §Walter Reed/Armed Forces Research Institute of Medical Sciences Research Unit-Nepal, Kathmandu, Nepal; ¶Association of Medical Doctors of Asia-Nepal, Kathmandu, Nepal; #US Army Medical Component of the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand

Main Article

Figure 3

Three-dimensional top view of the HA1 hemagglutinin structures for A) a representative A/Nepal/1648/04 virus and B) vaccine strain A/Wyoming/3/03. Most (24/26) of the Nepal isolates contain a lysine to asparagine substitution (shown in yellow) at position 145 (K145N). Magenta, residues 226 and 227; orange, residue 189; green, residues 155 and 156; yellow, residue 145. Hemagglutinin molecules were generated by using the respective amino acid sequences with MOLMOL (12). A/Nepal/1648/04 is availabl

Figure 3. . Three-dimensional top view of the HA1 hemagglutinin structures for A) a representative A/Nepal/1648/04 virus and B) vaccine strain A/Wyoming/3/03. Most (24/26) of the Nepal isolates contain a lysine to asparagine substitution (shown in yellow) at position 145 (K145N). Magenta, residues 226 and 227; orange, residue 189; green, residues 155 and 156; yellow, residue 145. Hemagglutinin molecules were generated by using the respective amino acid sequences with MOLMOL (12). A/Nepal/1648/04 is available from GenBank under accession no. AY945264.

Main Article

References
  1. CDC influenza weekly report: influenza summary update, questions and answers, the 2003–2004 influenza season. [cited 19 May 2005]. Available from http://www.cdc.gov/flu/about/qa/fluseason.htm
  2. Harper  SA, Fukuda  K, Uyeki  TM, Cox  NJ, Bridges  CB. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2004;53:1–40.
  3. Webster  RG, Kendal  AP, Gerhard  W. Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology. 1979;96:258–64. DOIPubMedGoogle Scholar
  4. Wiley  DC, Wilson  IA, Skehel  JJ. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 1981;289:373–8. DOIPubMedGoogle Scholar
  5. Wilson  AI, Cox  NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990;8:737–87. DOIPubMedGoogle Scholar
  6. Lee  MS, Chen  JS. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis. 2004;10:1385–90.PubMedGoogle Scholar
  7. Bush  RM, Bender  CA, Subbarao  K, Cox  NJ, Fitch  WM. Predicting the evolution of human influenza A. Science. 1999;286:1921–5. DOIPubMedGoogle Scholar
  8. Plotkin  JB, Dushoff  J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci U S A. 2003;100:7152–7. DOIPubMedGoogle Scholar
  9. Canas  LC, Lohman  K, Pavlin  JA, Endy  T, Singh  DL, Pandey  P, The Department of Defense laboratory-based global influenza surveillance system. Mil Med. 2000;165(Suppl 2):52–6.PubMedGoogle Scholar
  10. Daum  LT, Canas  LC, Smith  CB, Klimov  A, Huff  WB, Barnes  WJ, Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas. Emerg Infect Dis. 2002;8:408–12. DOIPubMedGoogle Scholar
  11. Kendal  AP, Pereura  MS, Skehel  J. Concepts and procedures for laboratory based influenza surveillance. Geneva: World Health Organization; 1982.
  12. Koradi  R, Billeter  M, Wuthrich  K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph. 1996;14:29–55, 51–5. DOIPubMedGoogle Scholar
  13. Guex  N, Peitsch  MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. •••;18:2714–23. DOIPubMedGoogle Scholar
  14. Cross  KJ, Burleigh  LM, Steinhauer  DA. Mechanisms of cell entry by influenza virus. Expert Rev Mol Med. 2001;6:1–18.PubMedGoogle Scholar
  15. Wilson  IA, Ladner  RC. Skehel, Wiley DC. The structure and role of the carbohydrate moieties of influenza virus hemagglutinin. Biochem Soc Trans. 1983;11:145–7.
  16. Hughey  PG, Roberts  PC, Holsinger  LJ, Zebedee  SL, Lamb  RA, Compans  RW. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology. 1995;212:411–21. DOIPubMedGoogle Scholar
  17. Zebedee  SL, Lamb  RA. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol. 1988;62:2762–72.PubMedGoogle Scholar
  18. Webster  RG, Brown  LE, Laver  WG. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies. Virology. 1984;135:30–42. DOIPubMedGoogle Scholar
  19. Okuno  Y, Isegawa  Y, Sasao  F, Ueda  S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol. 1993;67:2552–8.PubMedGoogle Scholar
  20. CDC weekly report: influenza summary update (week ending April 16, 2005). [cited 19 May 2005]. Available from http://www.cdc.gov/flu/weekly/

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external